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Abstract : As the expression level of allergic disease sensitive genes are correlated with the severity of allergic 
symptoms, suppression of these gene expressions could be promising therapeutics. We demonstrated that pro-
tein kinase Cδ / heat shock protein 90-mediated H1R gene expression signaling and nuclear factor of activated 
T-cells (NFAT)-mediated IL-9 gene expression signaling are responsible for the pathogenesis of pollinosis. Treat-
ment with Awa-tea combined with wild grape hot water extract suppressed these signaling and alleviated nasal 
symptoms in toluene-2,4-diisocyanate (TDI)-sensitized rats. However, the underlying mechanism of its anti-aller-
gic activity is not elucidated yet. Here, we sought to identify an anti-allergic compound from Awa-tea and pyro-
gallol was identified as an active compound. Pyrogallol strongly suppressed ionomycin-induced up-regulation 
of IL-9 gene expression in RBL-2H3 cells. Treatment with pyrogallol in combination with epinastine alleviated 
nasal symptoms and suppressed up-regulation of IL-9 gene expression in TDI-sensitized rats. Pyrogallol itself did 
not inhibit calcineurin phosphatase activity. However, pyrogallol suppressed ionomycin-induced dephosphory-
lation and nuclear translocation of NFAT. These data suggest pyrogallol is an anti-allergic compound in Awa-tea 
and it suppressed NFAT-mediated IL-9 gene expression through the inhibition of dephosphorylation of NFAT. 
This might be the underlying mechanism of the therapeutic effects of combined therapy of pyrogallol with anti-
histamine. J. Med. Invest. 67 : 289-297, August, 2020
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INTRODUCTION
 
Pollinosis is a seasonal allergic rhinitis (AR) caused by hy-
persensitivity to tree or grass pollens and affects approximately 
40% of the Japanese population (1). Histamine is one of the 
major chemical mediators of the allergic reaction and its action 
is mainly mediated through the activation of histamine H1 re-
ceptor (H1R). Therefore, antihistamines that antagonize H1R or 
suppress H1R constitutive activity as inverse agonist are widely 
used as the first-line medicine for pollinosis. Previously, we have 
demonstrated that H1R gene expression is correlated with the 
severity of symptoms in toluene-2,4-diisocyanate (TDI)-sensi-
tized rats and patients with pollinosis (2-4). We also showed that 
protein kinase Cδ (PKCδ) signaling was involved in H1R gene 
expression, and that suppression of the H1R gene up-regulation 
alleviated nasal symptoms in TDI-sensitized rats (5-11). 
In addition to histamine, Th2 cytokines, including Interleukin 
(IL)-4, IL-5, IL-9, and IL-13 are also involved in the pathogene-
sis of allergic symptoms (12). We have shown that Th2 cytokine 
gene expressions were up-regulated in TDI-sensitized rats, and 
suplatast, which did not suppress PKCδ signaling, suppressed 
TDI-induced up-regulation of Th2 cytokine gene expressions in 
TDI-sensitized rats (13). In addition, combination of suplatast 
with antihistamine markedly alleviated nasal symptoms in 
TDI-sensitized rats (14). Recently, we have reported that IL-9 
gene is an additional allergy sensitive gene in TDI-sensitized 
rats and nuclear factor of activated T-cells (NFAT) signaling is 
involved in IL-9 gene expression and that suppression of both 
PKCδ signaling and NFAT signaling remarkably improved 
nasal symptoms in allergy model rats (14). 
It is well known that fermentation of food produces many 
bioactive compounds such as antioxidant, anti-inflammatory, 
anti-diabetic, and anti-atherosclerotic activity (15). Previous-
ly, we showed that treatment with green-tea improved nasal 
symptoms and suppressed up-regulated H1R gene expression in 
TDI-sensitized rats (10). Awa-tea is a unique traditional tea in 
Tokushima, which consists of leaves fermented with Lactobacillus 
pentosus and Lactobacillus plantarum. It was reported that Awa-tea 
has anti-obesity activity (16). It was also reported that resorcinol 
was an active compound for its anti-oxidant activity (17). Fur-
thermore, Awa-tea suppressed mono- and disaccharides-induced 
increase in the blood glucose level in mice (18). Awa-tea has 
been traditionally used for the improvement of allergic symp-
toms in Tokushima, Japan. We have reported that treatment 
with Awa-tea combined with wild grape hot water extract that 
suppresses PKCδ signaling, markedly alleviated TDI-induced 
nasal symptoms and up-regulation of IL-9 gene expression in 
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TDI-sensitized rats (19). However, the underlying mechanism of 
its anti-allergic activity is not elucidated yet.
In this paper, we sought to identify an anti-allergic compound 
from Awa-tea. We investigated the effect of anti-allergic com-
pound on ionomycin-induced IL-9 gene expression in RBL-2H3 
cells. Then, we evaluated the effect of this compound on nasal 
symptoms in TDI-sensitized rats. We isolated and identified 
pyrogallol as an active compound in Awa-tea. Pyrogallol sup-
pressed up-regulation of Th2 cytokine genes including IL-4, 
IL-9, and IL-13. Treatment with pyrogallol improved nasal 
symptoms in TDI-sensitized rats. Combined treatment with 
pyrogallol with epinastine, an antihistamine, also markedly al-
leviated nasal symptoms in TDI-sensitized rats. Pyrogallol sup-
pressed dephosphorylation and nuclear translocation of NFAT in 
response to ionomycin stimulation in BHK cells overexpressing 
NFAT. These results suggest that pyrogallol improved nasal 
symptoms through the suppression of NFAT-mediated IL-9 gene 
up-regulation in TDI-sensitized rats. 
MATERIALS AND METHODS
Animals
Six-week-old male Brown Norway rats weighing 180-220 g 
(Japan SLC, Hamamatsu) were used for the present study. Rats 
were allowed free access to water and food and kept in a room 
at 25 ± 2°C and 55 ± 10% humidity with a 12-h light / dark cycle. 
The animals were divided into the control, sensitized with TDI 
(Wako Pure Chemical, Osaka), and test groups, with 4 rats in 
each group. All animal experiments were approved by the Eth-
ical Committee for Animal Research of Tokushima University. 
Sensitization and provocation with TDI
Rats were sensitized with TDI by the method described by 
Kitamura et al. with slight modifications (20). Briefly, 10 µl of 
10% TDI in ethyl acetate (Wako Pure Chemical) was applied bi-
laterally to the nasal vestibule once a day for 5 consecutive days. 
This sensitization procedure was then repeated after a 2-day 
interval. Nine days after the second sensitization, 10 µl of 10% 
TDI solution was again applied to the nasal vestibule to provoke 
nasal allergic-like symptoms. Control rats were treated with 
ethyl acetate only according to the same schedule (Fig. 1). Awa-
tea leaves (10 g) were boiled for 10 min in 1 L of water, and then 
extract was centrifuged, filtered, and freeze-dried extract was 
kept at -30°C until use. Awa-tea extract, re-dissolved in water 
on the day of the experiments, pyrogallol, and epinastine were 
administered orally 1 h before the TDI sensitization for 3 weeks 
(Fig. 1). The number of sneezes and the extent of watery rhi-
norrhea considered as the indicator of nasal allergic-symptoms 
and were determined using the protocol of Abe et al. (21). After 
TDI provocation, the number of sneezes and watery rhinorrhea 
severity were examined for 10 min. Scaling from 0 to 3 was used 
as the basis to estimate the level of watery rhinorrhea described 
in the Table 1.
Real-time quantitative RT-PCR
Nasal mucosa of rats was separated from the nasal septum, 
collected in RNAlater (Applied Biosystems, Foster City, CA, 
USA) 4 h after provocation with TDI, and stored at -80°C until 
used. Nasal mucosa was homogenized using a Polytron (Model 
PT-K ; Kinematica, AG, Littau / Luzern, Switzerland). Total 
RNA was isolated using RNAiso Plus reagent (Takara Bio Inc., 
Kyoto) according to the manufacturer’s instructions. RBL-2H3 
cells were cultured in Minimum Essential Medium Eagle con-
taining 10% fetal bovine serum (FBS), 100 IU / mL penicillin, 
and 100 µg / ml streptomycin. The cells were cultured to 70% 
confluency in six-well dishes. The cells were treated with Awa-
tea or pyrogallol for 24 h before treatment with 1 µM of iomomy-
cin. After the stimulation with ionomycin for 2 h, the cells were 
harvested, and total RNA was prepared using RNAiso Puls 
reagent. In the case of IgE / antigen stimulation, RBL-2H3 cells 
were treated with Awa-tea or pyrogallol for 6 h, then, treated 
with 100 ng / ml of monoclonal anti-dinitrophenyl (DNP)-IgE 
(Sigma-Aldrich) for 12 h. After the stimulation with anti-DNP-
IgE, the cells were stimulated with 100 ng / ml of DNP-albumin 
(Sigma-Aldrich) for 1 h, then the cells were harvested and total 
Fig 1.　Experimental protocol.
The rats were sensitized by intranasal application of 10 µl of 10% TDI for 2 weeks. After 1 week, the 
nasal symptoms were provoked using 10 µl of 10% TDI. The control group was sensitized with ethyl 
acetate only. Water extract of tea leaves, epinastine, and pyrogallol were administered orally once a day 
for 3 weeks. The drugs were administered 1 h before the rats were treated with TDI.
Table 1.　Criteria for grading the severity of TDI-induced nasal re-
sponses in rats.
Nasal response Score
0 1 2 3
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RNA were prepared. The RNA samples (2 µg) were reverse tran-
scribed to cDNA using PrimerScript RT Reagent Kit (Takara 
Bio Inc.). TaqMan primers and probe were designed using 
Primer Express software (Applied Biosystems). The nucleotide 
sequences of the primers and probes used in this study are 
summarized in Table 2. Real-time PCR was conducted using a 
GeneAmp 7300 sequence detection system (Applied Biosystems). 
To standardize the starting material, Rodent GAPDH Control 
Reagents (VICTM Probe ; Applied Biosystems) were used, and the 
data were expressed as the ratio to GAPDH mRNA.
Isolation and identification of active compound from Awa-tea
Awa-tea leaves (10 g) was mixed with 1 L of pure water at 90°C 
for 10 min. The extract was centrifuge at 3000xg for 10 min, 
resulting supernatant was passed through a filter paper, and the 
filtrate was freeze-dried (730 mg). The extract was re-dissolved 
in water and extracted using ethyl acetate. The water layer was 
then fractionated using butanol. The yield of each fraction was 
as follows ; ethyl acetate fraction (249 mg), butanol fraction (213 
mg), and water fraction (257 mg). Suppressive activity of IL-4 
gene expression in obtained fractions were analyzed. Next, ac-
tive fraction was applied on a Sephadex LH-20 column (2.5 φ × 21 
cm), and the column was eluted isocratically using acetone. Ac-
cording the developmental profiles of thin layer chromatography, 
fractions were classified 3 fractions and the suppressive activity 
of IL-9 gene expression of each fraction was assayed. The yield of 
each fraction was as follows ; fraction-1 (52.7 mg), fraction-2 (64.1 
mg), and fraction-3 (98.7 mg). The structure of the constituents 
in each fraction was identified using 1H-NMR and 13C-NMR.
Calcineurin assay
Phosphatase activity of calcineurin was calorimetrically 
assayed using calcineurin cellular activity assay kit (Enzo, 
Farmingdale, NY, USA). Briefly, recombinant calcineurin (40 
U / assay) was incubated with or without pyrogallol, INCA-6, 
an NFAT inhibitor (Tocris, Bristol, UK), or phosphatase in-
hibitor mix (PhosSTOP, Sigma-Aldrich) for 30 min at 30°C. 
RII phosphopeptide was used as a substrate. The reaction was 
stopped by the addition of 100 µl of BIOMOL reagent and further 
incubated for 30 min at room temperature. Then, absorbance at 
620 nm derived phosphates released by phosphatase reaction 
was measured using the Infinite M200 microplate reader (Tecan 
Japan, Kanagawa, Japan).
Immunoblot analysis
For immunoblot analysis, we used BHK-21 cells overex-
pressing EGFP-fused NFAT (22). BHK-21 cells were treated 
with pyrogallol (50-300 µM) for 10 min. Then, the cells were 
stimulated with 1 µM ionomycin for 30 min. After the stimula-
tion with ionomycin, the cells were harvested in Tris-buffered 
saline (TBS) containing proteinase inhibitors (cOmplete, Mini, 
Sigma-Aldrich) and phosphatase inhibitors (PhosSTOP), and 
whole cell extracts were prepared by sonication. For the immu-
noblot analysis, 30 µg of each protein sample was separated 
by 10% SDS-PAGE and then transferred onto a nitrocellulose 
membrane (Bio-Rad). The membrane was briefly rinsed in TBS 
containing 0.1% Tween 20 (TBS-T) and then incubated for 1 h 
at room temperature in TBS-T containing 5% skim milk (Difco). 
The membrane was then incubated with monoclonal anti-GFP 
antibody (JL-8) (BioRad) overnight at 4 °C. To detect β-actin, 
β-actin (8H10D10) mouse monoclonal antibody (Cell Signaling 
Technology Japan, Tokyo). Goat anti-mouse-HRP conjugate 
(Bio-Rad) was used as the secondary antibody, and proteins were 
visualized with an Immobilon Western Chemiluminescent HRP 
substrate (Merck Millipore, Billerica, MA, USA).
Subcellular localization of NFAT
BHK-21 cells were cultured in Dulbecco Modified Eagle Me-
dium, high glucose containing 10% fetal bovine serum (FBS), 5 
mg / ml puromycin (Nacalai Tesque, Kyoto Japan), 100 IU / mL 
penicillin, and 100 µg / ml streptomycin. The cells were placed 
onto 35-mm glass-bottomed dishes (AGC Techno Glass, Shizuoka, 
Japan). The cells were treated with pyrogallol (100 µM) for 24 h 
before stimulation with 1 µM of ionomycin. After stimulation, 
the cells were washed once with Ca2+-free PBS (PBS(-)) and fixed 
with 4% paraformaldehyde (Sigma-Aldrich) for 10 min at 4°C. 
Nuclear stain was conducted by the addition of 0.25 µg / ml of 
4’,6-diamidino-2-phenylindole (DAPI) in PBS(-) containing 1% 
BSA and 0.1% Tween 20 for 10 min. The subcellular localization 
of EGFP-tagged NFAT was determined using a confocal laser 
microscope (LSM510 ; Carl Zeiss, Oberkochen, Germany).
Statistical analysis
The results are indicated as means ± S.E.M. The statistical 
analysis was performed by One-way ANOVA with Dunnett’s 
test. P values less than 0.05 were considered significant.
RESULTS
Effect of fermentation of tea leaves on IgE / antigen (Ag)-stimulated 
up-regulation of IL-4 gene expression in RBL-2H3 cells and TDI-in-
duced nasal symptoms in TDI-sensitized rats
It is well known that fermentation of food produces many bio-
active compounds (15). As Awa-tea is tea fermented by lactic acid 
bacteria, it is speculated that Awa-tea has additional bioactive 
compounds. It is also known that Th2 cytokines are involved in 
the pathogenesis of allergic symptoms and IL-4 plays a central 
role in allergic inflammation (23). Thus, we investigated the ef-
fect of fermentation of tea leaves on IgE / Ag-stimulated IL-4 gene 
up-regulation in RBL-2H3 cells. The extract from fermented 
leaves dose dependently suppressed IgE / Ag-stimulated up-reg-
ulation of IL-4 gene expression in RBL-2H3 cells, while, the 
extract from non-fermented leaves showed weaker suppression 
(Fig. 2). Application of TDI for 3 weeks caused nasal symptoms 
in TDI-sensitized rats. Treatment with Awa-tea extract sup-
pressed TDI-induced nasal symptoms in TDI-sensitized rats 
(Fig. 3). These finding suggest that fermentation produced new 
anti-allergic compounds that suppress IL-4 gene up-regulation.










Anti-sense primer 5'- AGCGGAGCCTCTTCCAAGTAA -3'
Probe FAM-CTTCTCTCGAACGGACTCAGATACC
ACCT-TAMRA
For measuring rat IL-13 mRNA, primer probe kit from Applied 
Biosystems (Rn00587615) was used.
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Isolation and identification of active compound in Awa-tea extract
Water extract of Awa-tea leaves was firstly extracted using 
ethyl acetate. Then, the water layer was fractionated using buta-
nol. Ethyl acetate fraction showed suppression of IgE / Ag-stimu-
lated IL-4 gene up-regulation in RBL-2H3 cells (Fig. 4A). Either 
water fraction and butanol fraction showed no suppressive activ-
ity (Fig. 4 B and C). Next, active fraction was applied on a Sep-
hadex LH-20 column, and the column was eluted isocratically 
using acetone. According the developmental profiles of thin layer 
chromatography, fractions were classified 3 fractions. All frac-
tions showed suppression of IgE / Ag-stimulated up-regulation of 
IL-4 gene expression in RBL-2H3 cells (Fig. 4 D-F). Structural 
studies showed major constituent of fraction-1, fraction-2, and 
fraction-3 was pyrogallol, epicatechin (EC), and epigallocate-
chin (EGC), respectively. Therefore, we investigated the effect 
of these compound on IL-4 gene up-regulation. Pyrogallol sup-
pressed IgE / Ag-stimulated up-regulation of IL-4 gene expres-
sion (IC50 = 103 µM, Fig. 5A). EC and EGC also suppressed IL-4 
gene up-regulation, but less effective (IC50 = 480 µM and 147 
µM, respectively, Fig. 5B and C). Among these three compounds, 
EC and EGC were detected in the extracts from both fermented 
and non-fermented tea leaves. On the other hand, pyrogallol was 
detected only in the extract from fermented tea leaves (Awa-tea). 
Effect of pyrogallol on the expression of Th2 cytokine genes in RBL-
2H3 cells
Data suggest that anti-allergic compound in Awa-tea is py-
rogallol. Thus, we investigated the effect of pyrogallol on gene 
up-regulation of Th2 cytokine genes. Pyrogallol suppressed ion-
omycin-induced up-regulation of IL-4 and IL-9 gene expressions 
in RBL-2H3 cells (IC50 = 152 µM and 33.3 µM, respectively, Fig. 
6 A and B). Pyrogallol also suppressed IgE / Ag-stimulated IL-13 
gene up-regulation in RBL-2H3 cells (IC50 = 96.5 µM, Fig. 6C).
 
Effect of pyrogallol on TDI-induced nasal symptoms and IL-9 gene 
up-regulation in TDI-sensitized rats
Application of TDI for 3 weeks caused nasal symptoms in 
TDI-sensitized rats. Pretreatment with pyrogallol in combina-
tion with epinastine for 3 weeks improved TDI-induced nasal 
symptoms compared with epinastine alone (Fig. 7A and B). Ap-
plication of TDI for 3 weeks also up-regulated IL-9 gene expres-
sion. Treatment with pyrogallol alone suppressed TDI-induced 
IL-9 gene up-regulation in nasal mucosa of TDI-sensitized rats 
Fig 2.　Effect of fermentation of tea leaves on the suppression of IL-4 gene up-regulation in RBL-2H3 cells.
RBL-2H3 cells were treated with the extract from non-fermented (A) or fermented tea leaves (B) for 6 h, 
then, treated with 100 ng / ml of monoclonal anti-DNP-IgE for 12 h. After the stimulation with anti-DNP-IgE, 
the cells were stimulated with 100 ng / ml of DNP-albumin for 1 h, then the cells were harvested, and total 
RNA were prepared. IL-4 mRNA was determined by real-time quantitative RT-PCR. The data are expressed 
as means ± S.E.M. (n = 4). ##, p < 0.01 vs. control. **, p < 0.01 vs. IgE+Ag.
Fig 3.　Effect of the extract from fermented tea leaves (Awa-tea) on TDI-induced nasal symptoms in TDI-
sensitized rats.
The rats were sensitized and provoked as described in the Materials and Methods. The numbers of sneezes (A) 
and the nasal score (B) were measured over the 10-min period immediately after TDI provocation. The data 
were expressed as means ± S.E.M. (n = 4). ##, p < 0.01 vs. control. **, p < 0.01 vs. TDI.
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Fig 4.　Isolation of pyrogallol from Awa-tea extract.
Awa-tea leaves was extracted with 1 L of water at 90°C for 10 min. The extract was fractionated using ethyl acetate followed 
by butanol, and suppressive activity of IL-4 gene expression in ethyl acetate fraction (A), butanol fraction (B), and water 
fraction (C) were analyzed. (D), (E), and (F) ; Suppressive activity of IL-4 gene expression in fraction-1 (D), fraction-2 (E), 
and fraction-3 (F) obtained by the elution with acetone from a Sephadex LH20 column. RBL-2H3 cells were treated with 
fractions as described in Fig. 2, and IL-4 mRNA was determined by real-time quantitative RT-PCR. The data are expressed 
as means ± S.E.M. (n = 4). ##, p < 0.01 vs. control. **, p < 0.01; *, p < 0.05 vs. IgE+Ag.
Fig 5.　Effect of pyrogallol, epicatechin, and epigallocatechin on the suppression of IL-4 gene up-regulation in RBL-2H3 cells.
RBL-2H3 cells were treated with pyrogallol (A), epicatechin (B), and epigallocatechin (C) as described in Fig. 2, and IL-4 
mRNA was determined by real-time quantitative RT-PCR. The data are expressed as means ± S.E.M. (n = 4). ##, p < 0.01 vs. 
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(Fig. 7C). Treatment with pyrogallol combination with epinas-
tine also suppressed TDI-induced up-regulation of IL-9 gene 
expression in nasal mucosa of TDI-sensitized rats. On the other 
hand, treatment with epinastine alone didn’t show any suppres-
sion of IL-9 gene up-regulation (Fig. 7C).
Mechanism of suppression of NFAT signaling-mediated IL-9 gene 
expression by pyrogallol
Our data suggest that pyrogallol suppresses NFAT signaling. 
NFAT is activated through its dephosphorylation by calcineurin. 
Thus, we investigated the effect of pyrogallol on calcineurin 
phosphatase activity. As we expected, phosphatase inhibitor in-
hibited phosphate release from the substrate RII phosphopeptide 
(Fig. 8). INCA-6, a calcineurin-NFAT interaction inhibitor, does 
not indiscriminately block calcineurin substrates other than 
NFAT, thus, it slightly inhibited calcineurin phosphatase activ-
ity. On the other hand, pyrogallol did not inhibit phosphatase 
activity of calcineurin (Fig. 8). However, immunoblot analysis 
revealed that pyrogallol suppressed iomomycin-induced dephos-
phorylation of NFATc1 and NFATc2 by calcineurin (Fig. 9A). Py-
rogallol also inhibited ionomycin-induced nuclear translocation 
of NFATc1 and NFATc2 (Fig. 9B).
Fig 6.　Effect of pyrogallol on the expression of Th2 cytokine genes in RBL-2H3 cells.
RBL-2H3 cells were treated with pyrogallol as described in Fig. 2. In the case of ionomycin stimulation, the cells were treated 
with pyrogallol for 24 h before treatment with 1 µM of iomomycin. After the stimulation with ionomycin for 2 h, the cells were 
harvested and total RNA was prepared. The mRNA levels of IL-4 (A), IL-9 (B), and IL-13 (C) were determined by real-time 
quantitative RT-PCR. IO, ionomycin. The data are expressed as means ± S.E.M. (n = 4). ##, p < 0.01 vs. control. **, p < 0.01;*, 
p < 0.05 vs. ionomycin or IgE+Ag.
Fig 7.　Effect of pyrogallol in combination with epinastine on TDI-induced nasal symptoms and IL-9 mRNA up-regulation in 
TDI-sensitized rats.
The rats were sensitized and provoked as described in the Materials and Methods. Pyrogallol (24 mg / kg / day) and / or 
epinastine (24 mg / kg / day) were administered orally 1 h before the TDI sensitization for 3 weeks. The numbers of sneezes (A) 
and the nasal score (B) were measured over the 10-min period immediately after TDI provocation. The rats were sacrificed 
4 h after provocation with TDI, and total RNA was isolated. The mRNA levels of IL-9 (C) was determined by real-time 
quantitative RT-PCR. Epi, epinastine. Pyro, pyrogallol. Mix, epinastine + pyrogallol. The data were expressed as means ± 
S.E.M. (n = 4). ##, p < 0.01 vs. control. **, p < 0.01 vs. TDI. $$, p < 0.01 vs epinastine.
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DISCUSSION
In the present study, we isolated anti-allergic compound from 
hot water extract of Awa-tea leaves and identified pyrogallol 
as an active compound. Accumulating evidences suggest the 
biological effectiveness of fermented foods, especially fermented 
by lactic acid bacteria (15). During fermentation, lactic acid 
bacteria synthesize vitamins and minerals, and produce many 
biologically active compounds. In addition to histamine, Th2 cy-
tokines, including IL-4, IL-5, IL-9, and IL-13 also involve in the 
pathogenesis of allergic symptoms (12). Among them, IL-4 plays 
a central role in allergic inflammation, which is associated with 
the development of T lymphocytes, acts as a growth factor for 
Th2 cells, stimulates IgE synthesis, and is involved in mast cell 
activation (23). Fermented tea extract (Awa-tea) showed stronger 
suppression of IL-4 gene expression than non-fermented tea ex-
tract in RBL-2H3 cells, suggesting that Awa-tea contains addi-
tional compounds that do not exist in non-fermented tea extract. 
Therefore, we tried to purify the active compound in Awa-tea by 
monitoring IL-4 suppressive activity, and pyrogallol was identi-
fied as an active compound in Awa-tea. Besides suppression of 
IL-4 and IL-13 gene up-regulation, pyrogallol strongly suppressed 
Fig 8.　Effect of pyrogallol on calcineurin phosphatase activity.
Recombinant calcineurin and RII phosphopeptide were incubated with pyrogallol or INCA-6, or phosphatase inhibitors for 
30 min at 30°C. The reaction was stopped by the addition of 100 µl of BIOMOL reagent and further incubated for 30 min at 
room temperature. Then, absorbance at 620 nm derived phosphates released by phosphatase reaction was measured. The data 
are expressed as means ± S.E.M. (n = 4). **, p < 0.01 vs. control. 
Fig 9.　Effect of pyrogallol on dephosphorylation (A) and nuclear translocation (B) of NFAT in response to ionomycin stimulation.
(A), BHK-21 cells that overexpress EGFP-tagged NFATc1 or NFATc2 were treated with or without pyrogallol (50-300 µM) for 10 
min. Then, the cells were stimulated with 1 µM ionomycin for 30 min. After the stimulation with ionomycin, total cell lysates were 
isolated and subjected to immunoblot analysis. Cyclosporin A (2 µM) was used as a positive control. pNFATc1; phospho-NFATc1, 
pNFATc2; phospho-NFATc2, Cs A; cyclosporin A. In (B), RBL-2H3 cells were plated onto 35-mm glass-bottomed dishes. The cells 
were treated with pyrogallol (100 µM) for 10 min before stimulation with 1 µM of ionomycin. After the stimulation with ionomycin for 
30 min, the cells were fixed with 4% paraformaldehyde for 10 min at 4°C. Nuclear stain was conducted by the addition of 0.25 µg / ml 
of 4',6-diamidino-2-phenylindole (DAPI) in PBS(-) containing 1% BSA and 0.1% Tween 20 for 10 min. The subcellular localization of 
EGFP-tagged NFAT was determined using a confocal laser microscope. Scale bars = 20 µm.
pyrogallol ( M)
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ionomycin-induced up-regulation of IL-9 gene expression. Fur-
thermore, treatment with pyrogallol combined with epinastine 
that suppresses H1R gene expression signaling, markedly al-
leviated TDI-induced nasal symptoms and IL-9 up-regulation 
in TDI-sensitized rats. Previously, we showed that suplatast 
strongly suppressed ionomycin-induced IL-9 mRNA up-regula-
tion in RBL-2H3 cells, in which NFAT signaling is involved (14). 
We also showed that treatment with suplatast in combination 
with antihistamines markedly alleviated TDI-induced nasal 
symptoms and suppressed TDI-induced up-regulation of IL-9 
gene expression in TDI-sensitized rats (14). These data suggest 
that, similar to suplatast, pyrogallol suppresses NFAT-mediated 
IL-9 gene expression signaling, the 2nd intracellular signaling 
responsive for the pathogenesis of pollinosis. 
It was reported that IL-9 increased the expression of mast 
cell proteases and pro-allergic cytokines in cultured mast cells 
(24). It was also reported that neutralization of IL-9 by anti-IL-9 
antibody improved nasal symptoms and reduced the infiltration 
of eosinophils in the nasal mucosa, in which treatment with an-
ti-IL-9 antibody suppressed Th17 response and increased Treg 
response (25). These findings suggest that the IL-9 signaling 
plays an important role in the pathogenesis of pollinosis, and 
suppression of IL-9 gene up-regulation by pyrogallol is effective 
for alleviating nasal symptoms in patients with pollinosis. 
NFAT is first discovered as a transcription factor that binds 
to IL-2 promoter to activate cytokine production after T-cell ac-
tivation (26). It is now well-known that NFAT regulates not only 
T-cell activation and differentiation but also the function of other 
immune cells including dendritic cells and B-cells (27). NFAT 
consists of five isoforms including NFATc1, NFATc2, NFAT3, 
NFAT4, and NFAT5 (28). Among them, NFATc1 and NFATc2 
are most prominent NFAT family member in immune response. 
In NFAT signaling, NFAT is activated through its dephosphory-
lation by calcineurin. Then, activated NFAT is translocated into 
the nucleus, where it regulates the expression of genes that are 
involved in cell survival, proliferation and secretion of inflam-
matory mediators in cooperation with multiple transcriptional 
partners such as AP-1 (29). Pyrogallol itself did not inhibit pro-
tein phosphatase activity of calcineurin. However, pyrogallol in-
hibited NFATc1 and NFATc2 dephosphorylation by calcineurin, 
followed by their translocation into the nucleus, suggesting its 
suppression of NFAT signaling. 
In literature, anti-inflammatory activity of pyrogallol have 
been reported. For example, pyrogallol inhibited histamine re-
lease from RBL-2H3 cells stimulated with a calcium ionophore, 
A23187 (30). In our hand, pyrogallol as well as cyclosporin A sup-
pressed IgE / Ag-stimulated β-hexosaminidase release in RBL-
2H3 cells (Sawada and Mizuguchi unpublished data). These 
finding suggest the involvement of NFAT signaling in mast cell 
degranulation. It was reported that pyrogallol also inhibited 
the P. aeruginosa-dependent expression of the pro-inflammatory 
cytokine IL-6 (31). In TDI-sensitized rats, pyrogallol suppressed 
TDI-induced up-regulation of IL-6 gene expression in the nasal 
mucosa of rats (unpublished data). As IL-6 leads to an acute se-
vere systemic inflammatory response known as cytokine storm 
(32), pyrogallol might be useful for suppressing cytokine storm 
although precise molecular mechanism for its suppression of 
IL-6 gene expression is not clear at present.
In conclusion, we identified pyrogallol as an active compound 
from Awa-tea extract. Pyrogallol alleviated the nasal symptoms 
and suppressed IL-9 gene up-regulation in TDI-sensitized rats, 
possibly through the inhibition of NFAT signaling. This might be 
the underlying mechanism of the therapeutic effects of combined 
therapy of pyrogallol with antihistamine.
CONFLICT OF INTERESTS
All authors declare no financial conflicts of interest.
ACKNOWLEDGEMENTS
This work was financially supported in part by Grants-in-Aid 
for Scientific Research (C) from the Japan Society for the Promo-
tion of Science, and by a grant from the Osaka Medical Research 
Foundation for Intractable Diseases.
AUTHORS’ CONTRIBUTIONS
Tomohiro Nakano and Mitsuhiro Ikeda contributed equally 
to this work.
HM, NT, and HF designed the study and wrote the manu-
script. TN, MI, TW, and YK contributed to data collection and 
analysis. HM performed the statistical analysis. HM, OK, NK, 
MY, HF, YK, and HF performed interpretation of the results. All 
authors read and approved the final manuscript.
 
REFERENCES
1. Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, 
Kawauchi H, Suzaki H, Fujieda S, Masuyama K, Japanese 
Society of Allergology : Japanese guidelines for allergic rhi-
nitis. Allrgol Int 66 : 205-219, 2017 
2. Mizuguchi H, Hatano M, Matsushita C, Umehara H, 
Kuroda W, Kitamura Y, Takeda N, Fukui H : Repeated pre-
treatment with antihistamines suppresses transcriptional 
upregulations of histamine H1 receptor and interleukin-4 
genes in toluene-2,4-diisocyanate-sensitized rats. J Phar-
macol Sci 108 : 480-486, 2008
3. Mizuguchi H, Kitamura Y, Kondo Y, Kuroda W, Yoshida H, 
Miyamoto Y, Hattori M, Fukui H, Takeda N : Preseasonal 
prophylactic treatment with antihistamines suppresses 
nasal symptoms and expression of histamine H1 receptor 
mRNA in the nasal mucosa of patients with pollinosis. 
Methods Find Exp Clin Pharmacol 32 : 745-748, 2010
4. Kitamura Y, Nakagawa H, Fujii T, Sakoda T, Enomoto T, 
Mizuguchi H, Fukui H, Takeda N : Effects of antihistamine 
on up-regulation of histamine H1 receptor mRNA in the 
nasal mucosa of patients with pollinosis induced by con-
trolled cedar pollen challenge in an environmental exposure 
unit. J Pharmacol Sci 129 : 183-187, 2015
5. Das AK, Yoshimura S, Mishima R, Fujimoto K, Mizuguchi 
H, Dev S, Wakayama Y, Kitamura Y, Horio S, Takeda N, 
Fukui H : Stimulation of histamine H1 receptor up-reg-
ulates histamine H1 receptor itself through activation of 
receptor gene transcription. J Pharmacol Sci 103 : 374-382, 
2007
6. Mizuguchi H, Terao T, Kitai M, Ikeda M, Yoshimura Y, 
Das AK, Kitamura Y, Takeda N, Fukui H : Involvement 
of Protein Kinase Cδ / Extracellular Signal-regulated Ki-
nase / Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling 
Pathway in Histamine-induced Up-regulation of Histamine 
H1 Receptor Gene Expression in HeLa Cells. J Biol Chem 
286 : 30542-30551, 2011
7. Nariai Y, Mizuguchi H, Ogasawara T, Nagai H, Sasaki 
Y, Okamoto Y, Yoshimura Y, Kitamura Y, Nemoto H, 
Takeda N, Fukui H : Disruption of heat shock protein 90 
(Hsp90)-protein kinase C δ (PKCδ) interaction by (–)-maack-
iain suppress histamine H1 receptor gene transcription in 
297The Journal of Medical Investigation   Vol. 67  August  2020
HeLa cells. J Biol Chem 290 : 27393-27402, 2015 
8. Mizuguchi H, Nariai Y, Kato S, Nakano T, Kanayama 
T, Kashiwada Y, Nemoto H, Kawazoe K, Takahashi Y, 
Kitamura Y, Takeda N, Fukui H : Maackiain is a novel an-
tiallergic compound that suppresses transcriptional upregu-
lation of the histamine H1 receptor and interleukin-4 genes. 
Pharmacol Res Perspect 3, e00166, doi : 10.1002 / prp.166, 
2015
9. Hattori M, Mizuguchi H, Baba Y, Ono S, Nakano T, Zhang 
Q, Sasaki Y, Kobayashi M, Kitamura Y, Takeda N, Fukui 
H : Quercetin inhibit transcriptional up-regulation of hista-
mine H1 receptor via suppressing kinase C-δ / extracellular 
signal-regulated kinase / poly(ADP-ribose) polymerase-1 
signaling pathway in HeLa cells. Int Immunopharmacol 
15 : 232-239, 2013
10. Matsushita C, Mizuguchi H, Niino H, Sagesaka Y, 
Masuyama K, Fukui H : Identification of epigallocate-
chin-3-O-gallate as an active constituent in tea extract that 
suppresses transcriptional up-regulation of the histamine 
H1 receptor and interleukin-4 genes. J Transl Med 25 : 133-
142, 2008 
11. Shill MC, Mizuguchi H, Karmakar S, Kadota T, Mukherjee 
PK, Kitamura Y, Kashiwada Y, Nemoto H, Takeda N, Fukui 
H : A novel benzofuran, 4-methoxybenzofuraan-5-carbox-
amide, form Tephrosia purpurea suppressed histamine H1 
receptor gene expression through a protein kinase C-δ-de-
pendent signaling pathway. Int Immunopharmacol 30 : 18-
26, 2016
12. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE : The 
IL-4 receptor : signaling mechanisms and biologic func-
tions. Annu Rev Immunol 17 : 701-738, 1999
13. Shahriar M, Mizuguchi H, Maeyama K, Kitamura Y, 
Orimoto N, Horio S, Umehara H, Hattori M, Takeda N, 
Fukui H : Suplatast tosilate inhibits histamine signaling by 
direct and indirect downregulation of histamine H1 receptor 
gene expression through suppression of histidine decarbox-
ylase and IL-4 gene transcriptions. J Immunol 183 : 2133-
2141, 2009
14. Mizuguchi H, Orimoto N, Kadota T, Kominami T, Das AK, 
Sawada A, Tamada M, Miyagi K, Adachi T, Matsumoto 
M, Kosaka T, Kitamura Y, Takeda N, Fukui H : Suplatast 
tosilate alleviates nasal symptoms through the suppression 
of nuclear factor of activated T-cells-mediated IL-9 gene 
expression in toluene-2,4-diisocyanate-sensitized rats. J 
Pharmacol Sci 130 : 151-158, 2016 
15. Şanlier N, Gökcen BB, Sezgin AC : Health benefits of fer-
mented foods. Crit Rev Food Sci Nutr 59 : 506-527, 2019
16. Sogawa M, Seura T, Kohno S, Hirasaka K, Yamaguchi Y, 
Takayanagi R, Harada A, Okumura Y, Yamamoto S, Kishi 
K, Nikawa T : Awa (Tokushima) lactate-fermented tea as 
well as green tea enhance the effect of diet restriction on 
obesity in rats. J Med Invest 56 : 42-48, 2009 
17. Hiasa M, Kurokawa M, Ohta K, Esumi T, Akira H, Niki K, 
Yagi Y, Echigo N, Hatakeyama D, Kuzuhara T : Identifica-
tion and purification of resorucinol, an antioxidant specific 
to Awa-ban (pickled and anaerobically fermented) tea. Food 
Research International 54 : 72-80, 2013 
18. Hiasa M, Kurokawa M, Akira H, Harada M, Niki K, 
Ohta K, Shoji M, Echigo N, Kuzuhara T : Suppression 
of increased blood glucose levels in mice by Awa-ban tea 
following oral administration of mono - and disaccharides. 
Journal of Functional Foods 8 : 188-192, 2014 
19. Islam R, Mizuguchi H, Shaha A, Nishida K, Yabumoto M, 
Ikeda H, Fujino H, Kitamura Y, Fukui H, Takeda N : Effect 
of wild grape on the signaling of histamine H1 receptor gene 
expression responsible for the pathogenesis of allergic rhini-
tis. J Med Invest 65 : 242-250, 2018
20. Kitamura Y, Miyoshi A, Murata Y, Kalubi B, Fukui H, 
Takeda N : Effect of glucocorticoid on upregulation of hista-
mine H1 receptor mRNA in nasal mucosa of rats sensitized 
by exposure to toluene diisocyanate. Acta Otolaryngol 
124 : 1053-1058, 2004
21. Abe Y, Takeda N, Irifune M, Ogino S, Kalubi B, Imamura 
I, Fukui H, Wada H, Matsunaga T : Effects of capsaicin 
desensitization on nasal allergy-like symptoms and hista-
mine release in the nose induced by toluene diisocyanate in 
guinea pigs. Acta Otolaryngol 112 : 703-709, 1992 
22. Kitamura N, Shindo M, Ohtsuka J, Nakamura A, Tanokura 
M, Hiroi T, Kaminuma O : Identification of novel inter-
acting regions involving calcineurin and nuclear factor of 
activated T cells. FASEB J 34 : 3197-3208, 2020
23. Ricci M : IL-4 : a key cytokine in atopy. Clin Exp Allergy 
24 : 801-812, 1994
24. Wiener Z, Falus A, Toth S: IL-9 increases the expression 
of several cytokines in activated mast cells, while the IL-9-
induced IL-9 production is inhibited in mast cells of hista-
mine-free transgenic mice. Cytokine 26 : 122-130, 2004
25. Gu ZW, Wang YX, Cao ZW : Neutralization of interleukin-9 
ameliorates symptoms of allergic rhinitis by reducing Th2, 
Th9, and Th17 responses and increasing the Treg response 
in a murine model. Oncotarget 8 : 14314-14324, 2017
26. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree 
GR : Identification of a putative regulator of early T-cell acti-
vation genes. Science 241 : 202-205, 1988
27. Muller MR, Rao A : NFAT, immunity and cancer : a tran-
scription factor comes of age. Nature Rev Immunol 10 : 645-
656, 2010
28. Rao A, Luo C, Hogan PG : Transcription factors of the 
NFAT family : regulation and function. Annu Rev Immunol 
15 : 707-747, 1997
29. Knoops L, Renauld JC : IL-9 and its receptor : from signal 
transduction to tumorigenesis. Growth Factors 22 : 207-
215, 2004
30. Matsuo N, Yamada K, Shoji K, Mori M, Sugano M : Effect 
of tea polyphenols on histamine release from rat basophilic 
leukemia (RBL-2H3) cells : the structure-inhibitory activity 
relationship. Allergy 52 : 58-64, 1997
31. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini 
A, Bianchi N, Bezzerri V, Mancini I, Giri MG, Rizzotti P, 
Gambari R, Cabrini G : Pyrogallol, an active compound 
from the medicinal plant Emblica officinalis, regulates ex-
pression of pro-inflammatory genes in bronchial epithelial 
cells. Int Immunopharmacol 8 : 1672-1680, 2008
32. Tanaka T, Narazaki M, Kishimoto T : Immunotherapeutic 
implications of IL-6 blockade for cytokine storm. Immuno-
therapy 8 : 959-970, 2016
